• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by Cigna Corporation (Amendment)

    2/14/23 1:32:59 PM ET
    $CI
    Medical Specialities
    Health Care
    Get the next $CI alert in real time by email
    SC 13G/A 1 d390295dsc13ga.htm SC 13G/A SC 13G/A

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    WASHINGTON, D.C. 20549

     

     

    SCHEDULE 13G

    UNDER THE SECURITIES EXCHANGE ACT OF 1934

    (AMENDMENT NO. 1)*

     

     

    Cigna Corporation

    (Name of Issuer)

    Common Stock

    (Title of Class of Securities)

    125523100

    (CUSIP Number)

    December 31, 2022

    (Date of Event Which Requires Filing of this Statement)

     

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

    ☒ Rule 13d-1(b)

    ☐ Rule 13d-1(c)

    ☐ Rule 13d-1(d)

     

    *

    The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     


    CUSIP NO. 125523100    13G    PAGE 2 OF 4 PAGES

     

      1   

    NAME OF REPORTING PERSON

    S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

     

    Dodge & Cox    94-1441976

      2   

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

    (a)  ☐        (b)  ☐

     

    N/A

      3   

    SEC USE ONLY

     

      4   

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    California - U.S.A.

    NUMBER OF

    SHARES

     BENEFICIALLY  

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

          5     

    SOLE VOTING POWER

     

    10,925,157

          6     

    SHARED VOTING POWER

     

    0

          7     

    SOLE DISPOSITIVE POWER

     

    11,548,557

          8   

    SHARED DISPOSITIVE POWER

     

    0

    9   

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    11,548,557

    10   

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*

     

    N/A

    11   

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

     

    3.8%

    12   

    TYPE OF REPORTING PERSON*

     

    IA


    Item 1(a)

    Name of Issuer:

    Cigna Corporation

     

    Item 1(b)

    Address of Issuer’s Principal Executive Offices:

    900 Cottage Grove Road

    Bloomfield, Connecticut 06002

     

    Item 2(a)

    Name of Person Filing:

    Dodge & Cox

     

    Item 2(b)

    Address of the Principal Office or, if none, Residence:

    555 California Street, 40th Floor

    San Francisco, CA 94104

     

    Item 2(c)

    Citizenship:

    California - U.S.A.

     

    Item 2(d)

    Title of Class of Securities:

    Common Stock

     

    Item 2(e)

    CUSIP Number:

    125523100

     

    Item 3

    If the Statement is being filed pursuant to Rule 13d-1(b), or 13d-2(b), check whether the person filing is a:

    (e) ☒ Investment Advisor registered under section 203 of the Investment Advisors Act of 1940

     

    Item 4

    Ownership:

     

      (a)

    Amount Beneficially Owned:

    11,548,557

     

      (b)

    Percent of Class:

    3.8%


      (c)

    Number of shares as to which such person has:

     

      (i)

    sole power to vote or direct the vote:

    10,925,157

     

      (ii)

    shared power to vote or direct the vote:

    0

     

      (iii)

    sole power to dispose or to direct the disposition of:

    11,548,557

     

      (iv)

    shared power to dispose or to direct the disposition of:

    0

     

    Item 5

    Ownership of Five Percent or Less of a Class:

    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following ☒.

     

    Item 6

    Ownership of More than Five Percent on Behalf of Another Person:

    Not applicable.

     

    Item 7

    Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company:

    Not applicable.

     

    Item 8

    Identification and Classification of Members of the Group:

    Not applicable.

     

    Item 9

    Notice of Dissolution of a Group:

    Not applicable.

     

    Item 10

    Certification:

    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired in the ordinary course of business and were not acquired for the purpose of and do not have the effect of changing or influencing the control of the issuer of such securities and were not acquired in connection with or as a participant in any transaction having such purpose or effect.

    SIGNATURE

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

    Dated: February 14, 2023

     

    DODGE & COX
    By:  

    /S/ Katherine M. Primas

    Name:   Katherine M. Primas
    Title:   Chief Compliance Officer
    Get the next $CI alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CI

    DatePrice TargetRatingAnalyst
    2/6/2025$323.00Outperform → Mkt Perform
    Bernstein
    6/26/2024$400.00Overweight
    Piper Sandler
    5/30/2024$388.00Outperform
    Robert W. Baird
    3/6/2024$393.00Overweight
    Barclays
    2/5/2024$334.00 → $372.00Neutral → Overweight
    Cantor Fitzgerald
    2/5/2024$327.00 → $354.00Sector Perform → Outperform
    RBC Capital Mkts
    2/1/2024$355.00 → $370.00Hold → Buy
    Deutsche Bank
    1/4/2024$330.00 → $372.00Mkt Perform → Outperform
    Bernstein
    More analyst ratings

    $CI
    SEC Filings

    View All

    SEC Form 144 filed by The Cigna Group

    144 - Cigna Group (0001739940) (Subject)

    8/15/25 3:54:00 PM ET
    $CI
    Medical Specialities
    Health Care

    SEC Form 144 filed by The Cigna Group

    144 - Cigna Group (0001739940) (Subject)

    8/12/25 10:51:38 AM ET
    $CI
    Medical Specialities
    Health Care

    SEC Form 10-Q filed by The Cigna Group

    10-Q - Cigna Group (0001739940) (Filer)

    7/31/25 1:36:34 PM ET
    $CI
    Medical Specialities
    Health Care

    $CI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Skipping the Dentist? Not Anymore: Cigna Expands Access to Flexible Dental Payments, Driving Meaningful Increases in Preventive Care and Critical Procedures

    Program Now Expanding to 2.8 Million More Members Nationwide COLUMBIA, Mo., Aug. 5, 2025 /PRNewswire/ -- A flexible payment solution from Paytient and Cigna Healthcare® is helping more people get the dental care they need—when they need it—by removing cost as a barrier. New data shows a measurable increase in both preventive care and critical dental procedures among users. Now, the program is expanding to Cigna's mid-market segment, making it available to 2.8 million additional members nationwide. Initially rolled out to large-group clients like Hyatt, Advantage Solutions, and

    8/5/25 9:04:00 AM ET
    $CI
    Medical Specialities
    Health Care

    The Cigna Group Reports Strong Second Quarter 2025 Results, Reaffirms 2025 Adjusted EPS Outlook

    Total revenues for the second quarter 2025 increased 11% to $67.2 billionShareholders' net income for the second quarter 2025 was $1.5 billion, or $5.71 per shareAdjusted income from operations1 for the second quarter 2025 was $1.9 billion, or $7.20 per shareReaffirms 2025 outlook for adjusted income from operations1,2 of at least $29.60 per share2BLOOMFIELD, Conn., July 31, 2025 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) today reported strong second quarter 2025 results, reflecting continued growth and solid performance across its diverse portfolio of businesses. "Listening, adapting, and innovating to meet the evolving needs of our patients, customers, and clients ena

    7/31/25 6:00:00 AM ET
    $CI
    Medical Specialities
    Health Care

    The Cigna Group Declares Quarterly Dividend

    BLOOMFIELD, Conn., July 22, 2025 /PRNewswire/ -- The Board of Directors of The Cigna Group (NYSE: CI) today declared a cash dividend of $1.51 per share of its common stock, payable on September 18, 2025 to shareholders of record as of the close of business on September 4, 2025. About The Cigna Group The Cigna Group (NYSE:CI) is a global health company committed to creating a better future built on the vitality of every individual and every community. We relentlessly challenge ourselves to partner and innovate solutions for better health. The Cigna Group includes products and s

    7/22/25 4:33:00 PM ET
    $CI
    Medical Specialities
    Health Care

    $CI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    $CI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    The Cigna Group downgraded by Bernstein with a new price target

    Bernstein downgraded The Cigna Group from Outperform to Mkt Perform and set a new price target of $323.00

    2/6/25 7:05:01 AM ET
    $CI
    Medical Specialities
    Health Care

    Piper Sandler initiated coverage on The Cigna Group with a new price target

    Piper Sandler initiated coverage of The Cigna Group with a rating of Overweight and set a new price target of $400.00

    6/26/24 7:28:18 AM ET
    $CI
    Medical Specialities
    Health Care

    Robert W. Baird initiated coverage on The Cigna Group with a new price target

    Robert W. Baird initiated coverage of The Cigna Group with a rating of Outperform and set a new price target of $388.00

    5/30/24 7:35:19 AM ET
    $CI
    Medical Specialities
    Health Care

    Director Hennigan Michael J was granted 568 shares (SEC Form 4)

    4 - Cigna Group (0001739940) (Issuer)

    6/4/25 4:58:29 PM ET
    $CI
    Medical Specialities
    Health Care

    SEC Form 3 filed by new insider Hennigan Michael J

    3 - Cigna Group (0001739940) (Issuer)

    6/3/25 5:04:45 PM ET
    $CI
    Medical Specialities
    Health Care

    SEC Form 4 filed by Director Kurian George

    4 - Cigna Group (0001739940) (Issuer)

    6/3/25 5:04:40 PM ET
    $CI
    Medical Specialities
    Health Care

    $CI
    Financials

    Live finance-specific insights

    View All

    The Cigna Group Reports Strong Second Quarter 2025 Results, Reaffirms 2025 Adjusted EPS Outlook

    Total revenues for the second quarter 2025 increased 11% to $67.2 billionShareholders' net income for the second quarter 2025 was $1.5 billion, or $5.71 per shareAdjusted income from operations1 for the second quarter 2025 was $1.9 billion, or $7.20 per shareReaffirms 2025 outlook for adjusted income from operations1,2 of at least $29.60 per share2BLOOMFIELD, Conn., July 31, 2025 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) today reported strong second quarter 2025 results, reflecting continued growth and solid performance across its diverse portfolio of businesses. "Listening, adapting, and innovating to meet the evolving needs of our patients, customers, and clients ena

    7/31/25 6:00:00 AM ET
    $CI
    Medical Specialities
    Health Care

    The Cigna Group Declares Quarterly Dividend

    BLOOMFIELD, Conn., July 22, 2025 /PRNewswire/ -- The Board of Directors of The Cigna Group (NYSE: CI) today declared a cash dividend of $1.51 per share of its common stock, payable on September 18, 2025 to shareholders of record as of the close of business on September 4, 2025. About The Cigna Group The Cigna Group (NYSE:CI) is a global health company committed to creating a better future built on the vitality of every individual and every community. We relentlessly challenge ourselves to partner and innovate solutions for better health. The Cigna Group includes products and s

    7/22/25 4:33:00 PM ET
    $CI
    Medical Specialities
    Health Care

    The Cigna Group's Second Quarter 2025 Earnings Release Details

    BLOOMFIELD, Conn., June 25, 2025 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) will release its second quarter 2025 financial results on Thursday, July 31, 2025, and will host a conference call the same day. Second quarter 2025 financial results will be released no later than 6:30 a.m. Eastern Time (ET). Management will review these results on a conference call beginning at 8:30 a.m. ET. The call-in numbers are as follows: Live Call(888) 566-1889 (Domestic)(773) 799-3989 (International)Passcode: 07312025 Replay(800) 835-8067 (Domestic)(203) 369-3354 (Internat

    6/25/25 8:00:00 AM ET
    $CI
    Medical Specialities
    Health Care

    $CI
    Leadership Updates

    Live Leadership Updates

    View All

    The Cigna Group Announces Appointment of Michael J. Hennigan to Board of Directors

    BLOOMFIELD, Conn., June 2, 2025 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) announced today that Michael J. Hennigan has been appointed to the organization's Board of Directors. His appointment is effective June 2. Mr. Hennigan is the Executive Chairman of Marathon Petroleum Corporation (MPC), an integrated downstream energy company, and MPLX, a diversified master limited partnership formed by MPC. He joined the company in 2017 and previously held the roles of Chief Executive Officer of MPC and Chairman, President and Chief Executive Officer of MPLX. Prior

    6/2/25 4:30:00 PM ET
    $CI
    Medical Specialities
    Health Care

    The Cigna Group's "Community Vitality Project" Donates $75,000 to Nonprofits through Program Encouraging Fitness and Community Engagement

    As part of the company's initiative, thousands of employees logged 280,000 minutes of exercise over nine days Cigna leaders biked to Hartford, Conn.'s Dunkin' Park to host Boys & Girls Clubs members for a Yard Goats baseball game, with surprise appearances by UConn basketball coach and playersBLOOMFIELD, Conn., Sept. 9, 2024 /PRNewswire/ -- The Cigna Group (NYSE:CI) put out a challenge to its workforce this summer, inviting colleagues to join its first-ever Community Vitality Project, a nine-day challenge combining fun, fitness and fundraising. By logging more than 280,000 minutes of fitness activities and awarding their minutes spent moving, The Cigna Group employees helped determine how to

    9/9/24 7:00:00 AM ET
    $CI
    Medical Specialities
    Health Care

    The Cigna Group announces leadership changes to continue driving growth

    Brian Evanko to continue as Chief Financial Officer, will serve as new President and CEO of Cigna HealthcareAnn Dennison to join The Cigna Group as Deputy Chief Financial OfficerMike Triplett to retire by end of 2024 and Bryan Holgerson promoted to President of U.S. Commercial for Cigna HealthcareEric Palmer to assume expanded role leading enterprise strategy and corporate development, will continue as President and CEO of Evernorth Health ServicesBLOOMFIELD, Conn., Jan. 17, 2024 /PRNewswire/ -- The Cigna Group (NYSE:CI), a global health company, today announced leadership changes designed to continue accelerating growth across Evernorth Health Services and Cigna Healthcare.

    1/17/24 9:15:00 AM ET
    $CI
    Medical Specialities
    Health Care

    $CI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by The Cigna Group

    SC 13G - Cigna Group (0001739940) (Subject)

    11/12/24 9:55:14 AM ET
    $CI
    Medical Specialities
    Health Care

    SEC Form SC 13G/A filed by The Cigna Group (Amendment)

    SC 13G/A - Cigna Group (0001739940) (Subject)

    2/13/24 5:02:29 PM ET
    $CI
    Medical Specialities
    Health Care

    SEC Form SC 13G/A filed by The Cigna Group (Amendment)

    SC 13G/A - Cigna Group (0001739940) (Subject)

    2/9/24 8:50:20 AM ET
    $CI
    Medical Specialities
    Health Care